Corifollitropin alfa (Elonva®)

Assessment Status Rapid Review complete
Drug Corifollitropin alfa
Brand Elonva®
Indication Controlled Ovarian Stimulation (COS) in combination with a Gonadotropin Releasing Hormone (GnRH) antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program.
Assessment Process
Rapid review commissioned 22/09/2010
Rapid review completed 22/10/2010
Rapid review outcome Full Pharmacoeconomic Evaluation not Recommended.